Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.04 CNY
44.23 M CNY
2.18 B CNY
273.58 M
About ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD
Sector
Industry
CEO
Wei Yi Shen
Website
Headquarters
Taizhou
Founded
1997
ISIN
CNE1000026N8
FIGI
BBG006FTGD55
Zhejiang Starry Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of active ingredient and intermediate X-CT non-ionic contrast agent and fluoroquinolones series. Its products include fluorine quinoline derivatives, carbapenem, iohexol, ioversol, iopamidol, iopromide, iodixanol, levofloxacin, levofloxacin hydrochloride, levofloxacin acid ester, levofloxacin acid, pazufloxacin, pazufloxacin mesylate, meropenem, faropenem sodium, iomeprol, and gadobenate dimeglumine. The company was founded on September 15, 1997 and is headquartered in Taizhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 603520 is 8.78 CNY — it has decreased by −2.55% in the past 24 hours. Watch ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD stocks are traded under the ticker 603520.
603520 stock has fallen by −6.79% compared to the previous week, the month change is a −8.54% fall, over the last year ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD has showed a −36.83% decrease.
603520 reached its all-time high on Sep 1, 2020 with the price of 70.36 CNY, and its all-time low was 6.13 CNY and was reached on Oct 19, 2018. View more price dynamics on 603520 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
603520 stock is 3.90% volatile and has beta coefficient of 1.57. Track ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD stock price on the chart and check out the list of the most volatile stocks — is ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD there?
Today ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD has the market capitalization of 3.95 B, it has decreased by −4.94% over the last week.
Yes, you can track ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD financials in yearly and quarterly reports right on TradingView.
ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
603520 net income for the last quarter is −13.92 M CNY, while the quarter before that showed 10.62 M CNY of net income which accounts for −231.15% change. Track more ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD financial stats to get the full picture.
As of Dec 25, 2024, the company has 1.84 K employees. See our rating of the largest employees — is ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD on this list?
Like other stocks, 603520 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD stock shows the sell signal. See more of ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.